CRB is excited to welcome Alex Moore as a Senior Biopharma Specialist in the Maryland office. Moore has over twenty-two years of industry experience and has focused his time within the manufacturing engineering and facilities engineering fields.
Kurt Elam joined ACC/Lab Owl in 2017 with 20+ years of specialty biopharmaceutical experience, focused primarily on oncology, infectious disease, and critical care/ICU medicine. He has overseen and managed the successful launch of over 16 new FDA approved products/compounds or new indications, and worked to gain formulary approval in managed care organizations, thereby improving access for patients.
Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced the appointment of Michael Retterath as chief strategy officer.
Moustapha El-Amine, Ph.D. Joins Insmed Incorporated as Executive Director of Global Search and Evaluation (S&E)
Vigene Biosciences Appoints Audrey Chang, Ph.D. as VP of QC and Analytical Services
Olga Maltseva joins Catalio Capital Management LP as Head of Operations in Baltimore
Dave Hickey promoted to executive vice president and president, Life Sciences segment at BD
Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for quantifying the human proteome, today announced the appointment of Nick Nelson as Chief Business Officer.
Joerg Ahlgrimm Appointed as President and COO of The Discovery Labs.
Emmes President and CEO, Dr. Christine Dingivan
